| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Research Communications |
1 and ß1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting
a Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental Research, NIH, Bethesda, Maryland 20892–4370, USA
Laminin-1 is a basement membrane glycoprotein that promotes several biological activities including cell attachment, tumor metastasis, and angiogenesis. Angiogenesis plays an important role in tissue formation, reproduction, wound healing, and several pathological conditions. In this study, we screened 405 synthetic peptides from the 1 and ß1 chains to identify potential sites on laminin-1 active with endothelial cells. Peptides were initially screened by testing both endothelial cell adhesion to peptide-coated wells and tube formation on Matrigel in the presence of soluble peptide. Twenty active peptides were identified in these screens. A secondary screen using the rat aortic ring sprouting assay identified 13 of the 20 peptides that stimulated endothelial sprouting. Several of these active peptides were also found to stimulate human umbilical vein endothelial cell migration in Boyden chamber assays. Differences in the amount of peptide needed for the response and in the resultant morphologies/responses were observed between the peptides in all of the assays. Our results suggest that several active domains on laminin-1 may play important roles in stimulating different steps in angiogenesis.—Malinda, K. M., Nomizu, M., Chung, M., Delgado, M., Kuratomi, Y., Yamada, Y., Kleinman, H. K., Ponce, M. L. Identification of laminin 1 and ß1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J. 13, 53–62 (1999)
Key Words: angiogenesis • basement membrane • synthetic peptides
This article has been cited by other articles:
|
|
 |
|
  M. J. Kipper, H. K. Kleinman, and F. W. Wang New Method for Modeling Connective-Tissue Cell Migration: Improved Accuracy on Motility Parameters Biophys. J., September 1, 2007; 93(5): 1797 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Akalu, J. M. Roth, M. Caunt, D. Policarpio, L. Liebes, and P. C. Brooks Inhibition of Angiogenesis and Tumor Metastasis by Targeting a Matrix Immobilized Cryptic Extracellular Matrix Epitope in Laminin Cancer Res., May 1, 2007; 67(9): 4353 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hibino, M. Shibuya, M. P. Hoffman, J. A. Engbring, R. Hossain, M. Mochizuki, S. Kudoh, M. Nomizu, and H. K. Kleinman Laminin {alpha}5 Chain Metastasis- and Angiogenesis-Inhibiting Peptide Blocks Fibroblast Growth Factor 2 Activity by Binding to the Heparan Sulfate Chains of CD44 Cancer Res., November 15, 2005; 65(22): 10494 - 10501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Han, S. H. Oh, F. Morgillo, J. N. Myers, E. Kim, W. K. Hong, and H.-Y. Lee Hypoxia-inducible Factor 1{alpha} and Antiangiogenic Activity of Farnesyltransferase Inhibitor SCH66336 in Human Aerodigestive Tract Cancer J Natl Cancer Inst, September 7, 2005; 97(17): 1272 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Sulochana, H. Fan, S. Jois, V. Subramanian, F. Sun, R. M. Kini, and R. Ge Peptides Derived from Human Decorin Leucine-rich Repeat 5 Inhibit Angiogenesis J. Biol. Chem., July 29, 2005; 280(30): 27935 - 27948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Soriano, N. Liu, Y. Gao, Z.-J. Yao, T. Ishibashi, C. Underhill, T. R. Burke Jr., and D. P. Bottaro Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists Mol. Cancer Ther., October 1, 2004; 3(10): 1289 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hibino, M. Shibuya, J. A. Engbring, M. Mochizuki, M. Nomizu, and H. K. Kleinman Identification of an Active Site on the Laminin {alpha}5 Chain Globular Domain That Binds to CD44 and Inhibits Malignancy Cancer Res., July 15, 2004; 64(14): 4810 - 4816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dixelius, L. Jakobsson, E. Genersch, S. Bohman, P. Ekblom, and L. Claesson-Welsh Laminin-1 Promotes Angiogenesis in Synergy with Fibroblast Growth Factor by Distinct Regulation of the Gene and Protein Expression Profile in Endothelial Cells J. Biol. Chem., May 28, 2004; 279(22): 23766 - 23772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Givant-Horwitz, B. Davidson, and R. Reich Laminin-Induced Signaling in Tumor Cells: The Role of the Mr 67,000 Laminin Receptor Cancer Res., May 15, 2004; 64(10): 3572 - 3579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Suzuki, H. Nakatsuka, M. Mochizuki, N. Nishi, Y. Kadoya, A. Utani, S. Oishi, N. Fujii, H. K. Kleinman, and M. Nomizu Biological Activities of Homologous Loop Regions in the Laminin {alpha} Chain G Domains J. Biol. Chem., November 14, 2003; 278(46): 45697 - 45705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ruggeri, J. Singh, D. Gingrich, T. Angeles, M. Albom, H. Chang, C. Robinson, K. Hunter, P. Dobrzanski, S. Jones-Bolin, et al. CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models Cancer Res., September 15, 2003; 63(18): 5978 - 5991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Ponce, S. Hibino, A. M. Lebioda, M. Mochizuki, M. Nomizu, and H. K. Kleinman Identification of a Potent Peptide Antagonist to an Active Laminin-1 Sequence That Blocks Angiogenesis and Tumor Growth Cancer Res., August 15, 2003; 63(16): 5060 - 5064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Udayakumar, M. L. Chen, E. L. Bair, D. C. von Bredow, A. E. Cress, R. B. Nagle, and G. T. Bowden Membrane Type-1-Matrix Metalloproteinase Expressed by Prostate Carcinoma Cells Cleaves Human Laminin-5 {beta}3 Chain and Induces Cell Migration Cancer Res., May 1, 2003; 63(9): 2292 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Su, C. L. Cioffi, S. Stefansson, N. Mittereder, M. Garay, D. Hreniuk, and G. Liau Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1429 - H1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Okazaki, N. Suzuki, N. Nishi, A. Utani, H. Matsuura, H. Shinkai, H. Yamashita, Y. Kitagawa, and M. Nomizu Identification of Biologically Active Sequences in the Laminin alpha 4 Chain G Domain J. Biol. Chem., September 27, 2002; 277(40): 37070 - 37078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Engbring, M. P. Hoffman, A. J. Karmand, and H. K. Kleinman The B16F10 Cell Receptor for a Metastasis-promoting Site on Laminin-1 Is a Heparan Sulfate/Chondroitin Sulfate-containing Proteoglycan Cancer Res., June 1, 2002; 62(12): 3549 - 3554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Ruggeri, C. Robinson, T. Angeles, J. Wilkinson IV, and M. L. Clapper The Chemopreventive Agent Oltipraz Possesses Potent Antiangiogenic Activity in Vitro, ex Vivo, and in Vivo and Inhibits Tumor Xenograft Growth Clin. Cancer Res., January 1, 2002; 8(1): 267 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gebarowska, A. W. Stitt, T. A. Gardiner, P. Harriott, B. Greer, and J. Nelson Synthetic Peptides Interacting with the 67-kd Laminin Receptor Can Reduce Retinal Ischemia and Inhibit Hypoxia-Induced Retinal Neovascularization Am. J. Pathol., January 1, 2002; 160(1): 307 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. B. Seftor, E. A. Seftor, N. Koshikawa, P. S. Meltzer, L. M. G. Gardner, M. Bilban, W. G. Stetler-Stevenson, V. Quaranta, and M. J. C. Hendrix Cooperative Interactions of Laminin 5 {gamma}2 Chain, Matrix Metalloproteinase-2, and Membrane Type-1-Matrix/Metalloproteinase Are Required for Mimicry of Embryonic Vasculogenesis by Aggressive Melanoma Cancer Res., September 1, 2001; 61(17): 6322 - 6327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. PONCE, M. NOMIZU, and H. K. KLEINMAN An angiogenic laminin site and its antagonist bind through the {alpha}v{beta}3 and {alpha}5{beta}1 integrins FASEB J, June 1, 2001; 15(8): 1389 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-A. B. Gjerde, K. Woie, E. T. Wei, and R. K. Reed Lowering of interstitial fluid pressure after neurogenic inflammation is inhibited by mystixin-7 peptide Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1377 - H1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Griffioen and G. Molema Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Ponce, M. Nomizu, M. C. Delgado, Y. Kuratomi, M. P. Hoffman, S. Powell, Y. Yamada, H. K. Kleinman, and K. M. Malinda Identification of Endothelial Cell Binding Sites on the Laminin {gamma}1 Chain Circ. Res., April 2, 1999; 84(6): 688 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Gilbertson, M. E. Duff, J. W. West, J. D. Kelly, P. O. Sheppard, P. D. Hofstrand, Z. Gao, K. Shoemaker, T. R. Bukowski, M. Moore, et al. Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF alpha and beta Receptor J. Biol. Chem., July 13, 2001; 276(29): 27406 - 27414. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
